Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03994822 · ClinicalTrials.gov registry record · NA
pRESET for Occlusive Stroke Treatment
A NA study of Cardiovascular Diseases and Vascular Diseases, sponsored by phenox.
- Completed
- Registry status
- NA
- Development phase
- 340
- Enrollment target
- 20
- Study locations
NCT03994822 is a NA study of Cardiovascular Diseases and Vascular Diseases that has completed, run by phenox. The registered enrollment target is 340 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 20 study locations across 15 states.
The verdict
NCT03994822, a NA study of Cardiovascular Diseases and Vascular Diseases, has completed, sponsored by phenox.
- COMPLETED
- Registry status
- NA
- Development phase
- 340 participants
- Enrollment target
- 20
- Study locations
Study Summary
Compare the safety and effectiveness of pRESET to Solitaire in the treatment of stroke related to large vessel occlusion
Conditions Studied
Interventions
- DEVICE Mechanical Thrombectomy using the pRESET Thrombectomy device
- DEVICE Mechanical Thrombectomy using the Solitaire Revascularization Device
Study Locations (20)
New York
- Buffalo General Medical Center - Buffalo
- NYU Langone Health - New York
- The Mount Sinai Hosptial - New York
- Montefiore Medical Center - The Bronx
Florida
- University of Miami - Coral Gables
- Baptist Health Research Institute Jacksonville - Jacksonville
Illinois
- Rush University Medical Center - Chicago
- Advocate Lutheran General Hospital - Downers Grove
Arizona
- Honor Health Research Institute - Scottsdale
California
- Providence Little Company of Mary Medical Center - Santa Monica
Georgia
- Grady Memorial Hospital - Atlanta
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Massachusetts
- University of Massachusetts - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2019-10-04 |
| Est. Completion | 2022-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03994822
The ClinicalTrials.gov registry entry for NCT03994822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is phenox, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Mechanical Thrombectomy using the pRESET Thrombectomy device is the first listed.
NCT03994822 reports 20 study locations spanning 15 distinct geographic areas - top geographies include New York, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT03994822 about?
NCT03994822 is a clinical study titled "pRESET for Occlusive Stroke Treatment". Compare the safety and effectiveness of pRESET to Solitaire in the treatment of stroke related to large vessel occlusion
What is the current status of trial NCT03994822?
This trial is currently completed. It is a NA study. The enrollment target is 340 participants. The study started on 2019-10-04. Estimated completion is 2022-05-12.
What conditions does trial NCT03994822 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Vascular Diseases, Stroke, Ischemic, Stroke, Acute, Nervous System Diseases.
What interventions are being tested in trial NCT03994822?
The interventions under investigation include: Mechanical Thrombectomy using the pRESET Thrombectomy device (DEVICE), Mechanical Thrombectomy using the Solitaire Revascularization Device (DEVICE).
Who is sponsoring clinical trial NCT03994822?
This trial is sponsored by phenox, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03994822 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.